Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.
Intestinal bacteria play a role in the development of non-steroidal anti-inflammatory drugs (NSAID)-induced small intestinal injury. Agents such as probiotics, able to modify the gut ecology, might theoretically be useful in preventing small intestinal damage induced by NSAIDs. The clinical studies available so far do suggest that some probiotic agents can be effective in this respect.
Mario
M
Guslandi
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000494:pharmacology; D053704:Capsule Endoscopy; D006801:Humans; D015994:Incidence; D007410:Intestinal Diseases / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D007421:Intestine, Small / Q000187:drug effects / Q000293:injuries* / Q000473:pathology; D019936:Probiotics / Q000627:therapeutic use*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal